Cresemba (isavuconazonium sulfate) capsules — Highmark

Preferred products

• generic voriconazole

Initial criteria

• age ≥ 6 years
• If pediatric, weight ≥ 16 kg
• Diagnosis of aspergillosis infection (ICD-10: B44.9), classified as invasive
• Therapeutic failure, contraindication, or intolerance to generic voriconazole

Reauthorization criteria

• Prescriber attests to the presence of continued indicators of active disease (e.g., histopathology, fungal culture)

Approval duration

3 months